A PERSONALIZED iPSC-BASED THERAPY FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA DELIVERED VIA CELL SUSPENSION: PRE-CLINICAL DEVELOPMENT

Concurrent Speaker(s)

• 

  Ganna Bilousova, PhD (she/her/hers)

  University of Colorado Anschutz Medical Campus, USA